• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Tuberculosis lymphadenitis in Ethiopia
 
  • Details
  • Full
Options
2013
Journal Article
Title

Tuberculosis lymphadenitis in Ethiopia

Abstract
Tuberculosis (TB) is one of the most serious public health challenges in Ethiopia. Indeed, Ethiopia ranks 7th among 22 countries with a high burden of TB worldwide. Both pulmonary TB and extrapulmonary TB (EPTB) are issues of concern. Ethiopia ranks 3rd in terms of the number of EPTB patients worldwide, with TB lymphadenitis (TBL) being the most common. According to the World Health Organization' s Global TB Report 2009, the estimated number of TB patients in Ethiopia was 314,267 in 2007, with an estimated incidence rate of 378 patients per 100,000 population. Furthermore, 36% patients suffered from EPTB, with TBL accounting for 80% of these patients. In Ethiopia, pathological services, culture, and drug susceptibility testing for mycobacterium species are not available as routine tests, not even for cases with suspected infection by drug-resistant strains. Therefore, the management of multidrug-resistant (MDR) TB in Ethiopia is currently unsatisfactory. Against this background, a high index of clinical doubt and timely use of diagnostic methods, prompt confirmation of diagnosis, and early initiation of specific anti-TB treatment are the key factors for the successful management of MDR-TB and TBL in Ethiopia.
Author(s)
Biadglegne, Fantahun
University of Bahir Dar
Tesfaye, Weghata
University of Gondar
Anagaw, Belay
University of Gondar
Tessema, Belay
University of Gondar
Debebe, Tewodrose
University of Bahir Dar
Anagaw, Berhanu
Addis Ababa University
Mulu, Andargachew
University of Gondar
Sack, Ulrich
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Rodloff, Arne C.
Universität Leipzig
Journal
Japanese journal of infectious diseases : JJID  
DOI
10.7883/yoken.66.263
Additional full text version
Landing Page
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Keyword(s)
  • Ethiopia

  • MDR-TB

  • Tuberculosis

  • lymphadenitis

  • prevalence

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024